BFLY vs CBLL vs PRE Stock Comparison

Butterfly Network, Ceribell and Prenetics Global Prices as of Oct 28, 2026 Peers: Industry group
BFLY Butterfly Network, Inc.
$7.82 -14.5% 1M +253.8% 1Y
Market cap
$1.86B
P/E
–
Revenue (TTM)
$112.15M
Div. yield
–
Diagnostic Equipment Healthcare
3 wins
CBLL Ceribell, Inc.
$27.22 +11.1% 1M +112.2% 1Y
Market cap
$1.04B
P/E
–
Revenue (TTM)
$101.96M
Div. yield
–
Diagnostic Equipment Healthcare
1 win
PRE Prenetics Global Ltd
$18.52 -18.6% 1M +51.4% 1Y
Market cap
$312.51M
P/E
–
Revenue (TTM)
$185.92M
Div. yield
–
Diagnostic Equipment Healthcare
3 wins

Head to Head

7 decided of 12

Butterfly Network leads on 3 of the 12 questions below (Butterfly Network 3, Prenetics Global 3, Ceribell 1). Which ones matter depends on what you are buying for; a cheap multiple and slow growth often come together.

QuestionBFLYCBLLPRELeader
Larger companyMarket capitalisation $1.86B $1.04B $312.51M BFLY
Cheaper on earningsLower P/E, profitable companies only -27.4x -15.7x -3.7x –
Cheaper on forward earningsLower price / next fiscal year consensus EPS — — — –
Faster revenue growthRevenue growth, trailing twelve months +28.1% +31.7% +513.0% PRE
More profitableNet margin, trailing twelve months -66.7% -64.7% -38.2% PRE
Better return on capitalReturn on invested capital — — — –
Less leveragedLower net debt / EBITDA — 1.6x — –
Higher dividend yieldTrailing dividend yield — — 0.00% –
Better 1-year returnPrice return, last 12 months +253.8% +112.2% +51.4% BFLY
Better 5-year returnAnnualised price return, 5 years -5.4%/yr — -30.6%/yr BFLY
Less volatileAnnualised volatility, 1 year 115.0% 52.1% 80.7% CBLL
Higher overall scoreMean of the five percentile scores vs peers 45/100 39/100 51/100 PRE

Percentile Scorecard

BFLYCBLLPRE

Each axis is the mean percentile of its metrics against the company's industry group. 100 is the best in the group, 50 the middle.

Scores by Axis

AxisBFLYCBLLPRE
Valuation 29 #161 of 227 24 #173 of 227 35 #147 of 227
Growth 67 #72 of 219 23 #170 of 219 68 #70 of 219
Profitability 33 #138 of 205 38 #128 of 205 43 #117 of 205
Financial Health 61 #92 of 237 81 #47 of 237 58 #101 of 237
Shareholder Returns 37 #86 of 135 28 #97 of 135 –
Overall 45 39 51
  • BFLY ranked among 247 companies in Medical Devices and Diagnostics
  • CBLL ranked among 247 companies in Medical Devices and Diagnostics
  • PRE ranked among 247 companies in Medical Devices and Diagnostics

Price Performance

Price return, split-adjusted, before dividends. Click a name to hide or show it.

Returns

PeriodBFLYCBLLPRESPY
1 month -14.5%+11.1%-18.6% +0.9%
3 months +10.3%+53.5%+2.8% +5.9%
6 months +58.9%+41.4%+6.4% +8.5%
Year to date +105.8%+24.1%+17.6% +13.3%
1 year +253.8%+112.2%+51.4% +12.4%
3 years +889.9%—+230.5% +88.1%
3 years, per year +114.8%—+49.0% +23.5%
5 years -24.2%—-83.8% +68.2%
5 years, per year -5.4%—-30.6% +11.0%

Risk

MeasureBFLYCBLLPRESPY
Volatility, 1Y 115.0%52.1%80.7% 12.7%
Downside volatility, 1Y 91.7%49.7%73.9% 12.7%
Beta vs S&P 500, 1Y 3.011.211.53 1.00
Return / volatility, 1Y 2.212.150.64 0.98
Max drawdown, 5Y -93.4%-63.9%-97.6% -25.4%
From 52-week high -21.3%-1.7%-29.4% -0.9%
52-week high $9.94$27.68$26.25 $779.14
52-week low $1.97$10.92$11.79 $631.97

Valuation History

Weekly multiples on trailing twelve-month fundamentals. Negative or extreme readings (a loss year, a collapsed denominator) are left out so the chart stays readable.

MultipleBFLYCBLLPRE
P/E now vs peer median -27.4xmedian 28.8x -15.7xmedian 28.8x -3.7xmedian 28.8x
P/S now vs peer median 16.6xmedian 3.0x 10.2xmedian 3.0x 1.7xmedian 3.0x
EV/EBITDA now vs peer median -24.0xmedian 17.4x -13.6xmedian 17.4x -4.2xmedian 17.4x
P/FCF now vs peer median -66.4xmedian 25.7x -19.0xmedian 25.7x -6.1xmedian 25.7x
P/B now vs peer median 9.8xmedian 2.4x 8.1xmedian 2.4x 3.4xmedian 2.4x
PEG now vs peer median -1.01median 1.03 —median 1.03 -0.07median 1.03

Financial History

Reported figures by fiscal period, placed on the calendar year (or quarter) each period ended in, so companies with different fiscal years line up.

Trailing twelve monthsBFLYCBLLPRE
Revenue $112.15M $101.96M $185.92M
Gross profit $59.04M $90.65M $88.89M
Operating income -$79.38M -$69.97M -$61.83M
Net income -$74.85M -$66.00M -$71.99M
Free cash flow -$28.04M -$54.72M -$51.49M
R&D $38.10M $22.95M $4.11M
EPS (diluted) $-0.29 $-1.74 $-5.06
Cash & equivalents $124.66M $32.66M $59.05M
Total debt – $19.98M –
Shares (diluted) 262.10M 38.03M 14.05M
Enterprise value $1.30B $442.19M $176.24M

All Metrics

58 metrics · best in bold

Bold marks the best reading: the lowest positive value for multiples, leverage and payout, the highest for everything else. The bar under each value is its percentile against that company's own peers. Hover a value for its rank and the peer median.

Valuation

12 metrics
MetricBFLYCBLLPRE
P/E -27.4x -15.7x -3.7x
P/FCF -66.4x -19.0x -6.1x
P/Operating cash flow -77.5x -19.3x -6.1x
P/S 16.6x 10.2x 1.7x
P/B 9.8x 8.1x 3.4x
P/Tangible book 10.2x 8.1x 3.4x
EV/EBITDA -24.0x -13.6x -4.2x
EV/EBIT -21.9x -13.3x -4.1x
EV/Revenue 15.5x 9.1x 1.4x
EV/FCF -61.9x -17.0x -4.9x
EV/Operating cash flow -72.3x -17.2x -4.9x
PEG (3Y EPS CAGR) -1.01 – -0.07

Growth

14 metrics
MetricBFLYCBLLPRE
Revenue growth (1Y) 28.1% 31.7% 513.0%
Revenue CAGR (3Y) 15.6% – 115.5%
Gross profit growth (1Y) 8.8% 33.4% 413.6%
Gross profit CAGR (3Y) 13.3% – 127.9%
Operating income growth (1Y) -14.8% -34.6% -49.2%
Operating income CAGR (3Y) 21.1% – -1.9%
Net income growth (1Y) -19.1% -33.6% -60.1%
Net income CAGR (3Y) 20.8% – -16.5%
EPS growth (1Y) -12.9% -27.5% -28.5%
EPS CAGR (3Y) 27.0% – 52.8%
Operating cash flow growth (1Y) 19.6% -44.3% –
Operating cash flow CAGR (3Y) 44.5% – –
Free cash flow growth (1Y) 12.2% -41.8% –
Free cash flow CAGR (3Y) 42.8% – –

Profitability

14 metrics
MetricBFLYCBLLPRE
Gross margin 52.6% 88.9% 47.8%
EBITDA margin -64.4% -67.1% -32.6%
Operating margin -70.8% -68.6% -33.3%
Pretax margin -66.7% -64.7% -24.2%
Net margin -66.7% -64.7% -38.2%
FCF margin -25.0% -53.7% -27.7%
Operating cash flow margin -21.4% -53.0% -27.7%
Return on equity -39.3% -49.0% -67.3%
Return on assets -26.3% -38.3% -43.8%
Return on invested capital – – –
Return on capital employed -35.1% -45.1% -48.3%
Asset turnover 0.4x 0.6x 1.1x
Cash conversion (OCF / net income) 0.3x 0.8x 0.7x
Stock comp / revenue 21.3% 16.1% 3.4%

Financial Health

11 metrics
MetricBFLYCBLLPRE
Debt / assets – 12.0% –
Debt / equity – 0.2x –
Net debt / EBITDA – 1.6x –
Debt / FCF – -0.4x –
Liabilities / assets 33.1% 22.9% 39.5%
Equity / assets 66.9% 77.1% 60.5%
Interest coverage -59.4x -38.6x –
Current ratio 4.1x 9.2x 4.0x
Quick ratio 2.7x 8.6x 1.8x
Cash ratio 2.1x 7.5x 1.6x
Altman Z-score 7.69 14.47 –

Shareholder Returns

7 metrics
MetricBFLYCBLLPRE
Dividend yield – – –
Net buyback yield -0.4% -0.6% –
Shareholder yield -0.4% -0.6% 0.0%
Payout ratio (earnings) – – –
Payout ratio (FCF) – – –
Dividend growth (1Y) – – –
Dividend CAGR (3Y) – – –

Analyst Estimates

Solid lines are reported fiscal-year results; dashed lines are the consensus for the years ahead. Hover a year for the analysts' high and low, and how each result compared with its estimate.

ConsensusBFLYCBLLPRE
EPS, next fiscal year $-0.10FY2026 $-1.86FY2026 $-3.42FY2026
Revenue, next fiscal year $114.50MFY2026 $118.32MFY2026 $234.43MFY2026
Revenue growth, next FY +17.3%FY2026 +32.9%FY2026 +153.7%FY2026
Revenue growth, the year after +26.0% +21.1% +65.3%

Institutional Ownership

13F filings, quarter ended Jun 30, 2026
HoldersBFLYCBLLPRE
Held by institutions 59.9% 79.9% 0.9%
Institutions holding 245 124 1
Change in shares held, QoQ +13.9% +2.2% –
Institutions buying 143 74 0
Institutions selling 59 36 0
Buyers to sellers 2.42 2.06 –

Return Correlation

Daily returns, last 12 months

1.00 means two stocks move in lockstep, 0 that they move independently. Pairs below about 0.5 diversify each other.

BFLYCBLLPRE
BFLY 1.00 0.37 0.25
CBLL 0.37 1.00 0.13
PRE 0.25 0.13 1.00

Add a Peer

Largest companies in the same industry

Related Comparisons

Frequently Asked Questions

Which is bigger, BFLY, CBLL and PRE?

Butterfly Network (BFLY) is the largest by market capitalisation: Butterfly Network (BFLY) $1.86B, Ceribell (CBLL) $1.04B, Prenetics Global (PRE) $312.51M.

Which company is growing faster?

Prenetics Global (PRE) grew revenue fastest over the trailing twelve months: Butterfly Network (BFLY) +28.1%, Ceribell (CBLL) +31.7%, Prenetics Global (PRE) +513.0%.

Which company is more profitable?

Prenetics Global (PRE) has the highest net margin (Butterfly Network (BFLY) -66.7%, Ceribell (CBLL) -64.7%, Prenetics Global (PRE) -38.2%).

Which stock has performed better?

Over the past year Butterfly Network (BFLY) returned the most: Butterfly Network (BFLY) +253.8%, Ceribell (CBLL) +112.2%, Prenetics Global (PRE) +51.4%. Over five years, Butterfly Network (BFLY) compounded fastest (Butterfly Network (BFLY) -5.4%/yr, Prenetics Global (PRE) -30.6%/yr). Returns are price only, before dividends.

Which stock is riskier?

By one-year price volatility, Ceribell (CBLL) has been the steadiest (Butterfly Network (BFLY) 115.0%, Ceribell (CBLL) 52.1%, Prenetics Global (PRE) 80.7%). Volatility measures how widely the price swings, not the risk of the business.

Which is the better stock, BFLY, CBLL and PRE?

There is no single answer; it depends on what you are buying for. On the 12 head-to-head measures on this page, Butterfly Network (BFLY) leads on 3. Business Quant does not give investment advice; use the comparison as a starting point for your own research.

Data from SEC filings, exchange prices and consensus estimates, via Business Quant. Percentile scores compare each company with its own peer group, so two companies' scores are each relative to different peers unless you rank against the whole market. Price returns exclude dividends. Nothing on this page is investment advice.